Physician

Amy R Auerbach, M.D.

According to 2025 Medicare claims, Amy Auerbach, M.D. (NPI: 1831392877) practices allergy/immunology in the York-Hanover, PA market, with the plurality of this provider's patient population coming from York, PA. This provider's primary affiliated billing organization is PSF PLLC (NPI: 1881785947; TIN: 611389493) and primary practice location at 17403-4637.

Auerbach's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 351 traditional Medicare patients, billed 22,784 HCPCS/CPT codes, and received $406,772 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 584 prescription claims across 192 beneficiaries totaling $251,991 in drug costs, led by Dupixent Syringe (Dupilumab). DME data shows 176 claims. Open Payments data shows 17 records totaling $410. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $209,713 to $406,772. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $66,729 to $251,991. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $1,156 to $3,786.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	358	16,389	$209,713
2016	369	13,644	$156,107
2017	374	14,959	$184,396
2018	368	14,049	$199,736
2019	425	16,002	$222,736
2020	441	18,843	$325,634
2021	422	17,381	$284,425
2022	379	15,945	$233,063
2023	380	18,017	$275,782
2024	351	22,784	$406,772

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	157	501	$66,729
2016	154	489	$66,686
2017	154	539	$78,031
2018	130	527	$78,701
2019	146	535	$77,815
2020	166	614	$116,516
2021	182	552	$129,952
2022	180	519	$143,804
2023	187	528	$154,090
2024	192	584	$251,991

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	47	$42,521
2016	N/R	58	$67,005
2017	N/R	72	$63,135
2018	N/R	97	$83,717
2019	N/R	190	$136,900
2020	N/R	180	$220,742
2021	N/R	197	$284,356
2022	N/R	249	$342,301
2023	N/R	208	$293,623
2024	N/R	176	$284,529

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	76	76	$109
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	77	80	$63
95165	Professional service for preparation and provision of 1 or more antigens	172	3,560	$10
95117	Professional service for multiple injections of allergen	184	3,210	$8
95004	Test for allergy using allergenic extract	80	5,259	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Syringe	Dupilumab	14	392	$54,614
Dupixent Pen	Dupilumab	13	364	$49,857
Arnuity Ellipta	Fluticasone Furoate	55	2,850	$25,116
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	750	$15,658
Breo Ellipta	Fluticasone/Vilanterol	22	660	$8,092

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	55	$260,125
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	N	N/R	12	$16,685
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	12	$3,956
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	47	$3,007
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	50	$756

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$410	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amy R. Auerbach, M.D.?

Tedicare shows public-source Medicare data for Amy R. Auerbach, M.D. (NPI 1831392877), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amy R. Auerbach, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amy R. Auerbach, M.D.?

Amy R. Auerbach, M.D. is linked to PSF PLLC (billing NPI 1881785947) in the available physician profile data.

Does Amy R. Auerbach, M.D. have Open Payments data?

Amy R. Auerbach, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.